You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Atenolol, a beta-blocking agent, reduced blood pressure and heart rate in patients with essential hypertension. While initially decreasing left ventricular function, it showed improvement over 8 weeks, suggesting low risk for heart decompensation.
Area of Science:
Context:
Purpose:
Summary:
Impact: